---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-026683"
form_type: "8-K"
ticker: "SRPT"
cik: "0000873303"
company_name: "Sarepta Therapeutics, Inc."
filed_at: "2025-02-14T23:59:59+00:00"
generated_at: "2026-05-26T21:49:18.616235+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Sarepta enters $600M senior secured revolving credit facility with JPMorgan as admin agent

## Summary
- Five-year $600M revolving credit facility closed Feb 13, 2025; variable interest at Adjusted SOFR + 1.125%-1.75% spread based on leverage.
- Financial covenants: max secured net leverage ratio 3.5:1.0 (4.0:1.0 holiday for acquisitions); min interest coverage ratio 2.5:1.0.
- Facility matures Feb 13, 2030; proceeds for general corporate purposes; secured by substantially all assets of obligors.
- Commitment fee on unused portion ranges from 0.20% to 0.35% per annum based on total gross leverage ratio.
- Lead arrangers include JPMorgan, Barclays, Citizens, Goldman Sachs, Morgan Stanley, and RBC as co-syndication agents.

## SEC filing metadata
- accession: 0001193125-25-026683
- form_type: 8-K
- ticker: SRPT
- cik: 0000873303
- company_name: Sarepta Therapeutics, Inc.
- filed_at: 2025-02-14T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/873303/000119312525026683/0001193125-25-026683-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/873303/000119312525026683/d875089d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-026683
- JSON: https://secwatch.observer/filing/0001193125-25-026683.json
- Plain text: https://secwatch.observer/filing/0001193125-25-026683.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.